학술논문
A multiplex UPLC-MS/MS method for the quantification of three PD-L1 checkpoint inhibitors, atezolizumab, avelumab, and durvalumab, in human serum
Document Type
Article
Author
Source
In Journal of Pharmaceutical and Biomedical Analysis 15 June 2024 243
Subject
Language
ISSN
0731-7085